Clinical trial
A Phase 1/2. Multicenter, Randomized, Double-blinded, Placebo and Active-controlled, Parallel Study for Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients
NCT05346783 is registered in ClinicalTrials.gov with Taejoon Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2. Multicenter, Randomized, Double-blinded, Placebo and Active-controlled, Parallel Study for Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients
- Lead sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- October 14, 2021
- Completion date
- June 30, 2023
- Enrollment
- 98 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.